drugset / Trial / NCT00280371

A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD

NCT00280371 ↗

Phase 3 Completed 345 enrolled Dey
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.

Timeline

Start
2006-01
Primary completion
2006-07
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified 20 ug Inhaled